Oral Candida administration in a Clostridium difficile mouse model worsens disease severity but is attenuated by Bifidobacterium

PLoS ONE

Volumn 14, Issue 1, 2019, Pages

  Panpetch, Wimonrat ^a   Somboonna, Naraporn ^b   Palasuk, Matanee ^b   Hiengrach, Pratsanee ^a   Finkelman, Malcolm ^c   Tumwasorn, Somying ^a   Leelahavanichkul, Asada ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECTIN 1; DNA 18S; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 2; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR; CXCL8 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM CATENULATUM; BODY WEIGHT LOSS; CACO-2 CELL LINE; CANDIDEMIA; CLOSTRIDIUM DIFFICILE INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; DNA DETERMINATION; FECES MICROFLORA; FUNGAL COLONIZATION; HT-29 CELL LINE; HUMAN; HUMAN CELL; MALE; MORTALITY RATE; MOUSE; MOUSE MODEL; NONHUMAN; PATHOGEN LOAD; PICHIA; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; SURVIVAL RATE; TISSUE LEVEL; TRICHOSPORON; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CANDIDA ALBICANS; CLOSTRIDIUM INFECTION; DISEASE MODEL; INTESTINE FLORA; INTESTINE MUCOSA; MICROBIOLOGY; MYCOBIOME; ORAL DRUG ADMINISTRATION; PATHOGENICITY; PATHOPHYSIOLOGY; PERMEABILITY; PHYSIOLOGY;

ADMINISTRATION, ORAL; ANIMALS; BIFIDOBACTERIUM; CACO-2 CELLS; CANDIDA ALBICANS; CLOSTRIDIUM INFECTIONS; DISEASE MODELS, ANIMAL; GASTROINTESTINAL MICROBIOME; HT29 CELLS; HUMANS; INTERLEUKIN-8; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; MYCOBIOME; PERMEABILITY; PROBIOTICS;

EID: 85060034059     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0210798     Document Type: Article

References (41)

1. Evans CT, Safdar N. Current Trends in the Epidemiology and Outcomes of Clostridium difficile Infection. Clin Infect Dis. 2015; 60 Suppl 2:S66–71. https://doi.org/10.1093/cid/civ140 PMID: 25922403
2. Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015; 372(16):1539–48. https://doi.org/10.1056/NEJMra1403772 PMID: 25875259
3. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med. 1994; 330(4):257–62. https://doi.org/10.1056/NEJM199401273300406 PMID: 8043060
4. Libby DB, Bearman G. Bacteremia due to Clostridium difficile—review of the literature. Int J Infect Dis. 2009; 13(5):e305–9. https://doi.org/10.1016/j.ijid.2009.01.014 PMID: 19398213
5. Leelahavanichkul A, Panpetch W, Worasilchai N, Somparn P, Chancharoenthana W, Nilgate S, et al. Evaluation of gastrointestinal leakage using serum (1—>3)-beta-D-glucan in a Clostridium difficile murine model. FEMS Microbiol Lett. 2016; 363(18). https://doi.org/10.1093/femsle/fnw204 PMID: 27573235
6. Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut. 2006; 55(10):1512–20. https://doi.org/10.1136/gut.2005.085373 PMID: 16966705
7. Zekovic DB, Kwiatkowski S, Vrvic MM, Jakovljevic D, Moran CA. Natural and modified (1—>3)-beta-D-glucans in health promotion and disease alleviation. Crit Rev Biotechnol. 2005; 25(4):205–30. https://doi.org/10.1080/07388550500376166 PMID: 16419618
8. Panpetch W, Somboonna N, Bulan DE, Issara-Amphorn J, Worasilchai N, Finkelman M, et al. Gastrointestinal Colonization of Candida Albicans Increases Serum (1—>3)-beta-D-Glucan, without Candide-mia, and Worsens Cecal Ligation and Puncture Sepsis in Murine Model. Shock. 2017. https://doi.org/10.1097/SHK.0000000000000896 PMID: 28498297
9. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev. 2005; 18(2):247–63. https://doi.org/10.1128/CMR.18.2.247-263.2005 PMID: 15831824
10. Samonis G, Anastassiadou H, Dassiou M, Tselentis Y, Bodey GP. Effects of broad-spectrum antibiotics on colonization of gastrointestinal tracts of mice by Candida albicans. Antimicrob Agents Chemother. 1994; 38(3):602–3. PMID: 8203861
11. Yamaguchi N, Sonoyama K, Kikuchi H, Nagura T, Aritsuka T, Kawabata J. Gastric colonization of Candida albicans differs in mice fed commercial and purified diets. J Nutr. 2005; 135(1):109–15. https://doi.org/10.1093/jn/135.1.109 PMID: 15623841
12. Koh AY. Murine models of Candida gastrointestinal colonization and dissemination. Eukaryot Cell. 2013; 12(11):1416–22. https://doi.org/10.1128/EC.00196-13 PMID: 24036344
13. Panpetch W, Somboonna N, Bulan DE, Issara-Amphorn J, Finkelman M, Worasilchai N, et al. Oral administration of live- or heat-killed Candida albicans worsened cecal ligation and puncture sepsis in a murine model possibly due to an increased serum (1—>3)-beta-D-glucan. PLoS One. 2017; 12(7): e0181439. https://doi.org/10.1371/journal.pone.0181439 PMID: 28750040
14. Yamaguchi N, Sugita R, Miki A, Takemura N, Kawabata J, Watanabe J, et al. Gastrointestinal Candida colonisation promotes sensitisation against food antigens by affecting the mucosal barrier in mice. Gut. 2006; 55(7):954–60. https://doi.org/10.1136/gut.2005.084954 PMID: 16423887
15. Ballou ER, Avelar GM, Childers DS, Mackie J, Bain JM, Wagener J, et al. Lactate signalling regulates fungal beta-glucan masking and immune evasion. Nat Microbiol. 2016; 2:16238. https://doi.org/10.1038/nmicrobiol.2016.238 PMID: 27941860
16. Kikkert R, Bulder I, de Groot ER, Aarden LA, Finkelman MA. Potentiation of Toll-like receptor-induced cytokine production by (1—>3)-beta-D-glucans: implications for the monocyte activation test. J Endotoxin Res. 2007; 13(3):140–9. Epub 2007/07/11. https://doi.org/10.1177/0968051907080024 PMID: 17621556
17. Laukens D, Brinkman BM, Raes J, De Vos M, Vandenabeele P. Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design. FEMS Microbiol Rev. 2016; 40(1):117–32. https://doi.org/10.1093/femsre/fuv036 PMID: 26323480
18. Hutton ML, Mackin KE, Chakravorty A, Lyras D. Small animal models for the study of Clostridium difficile disease pathogenesis. FEMS Microbiol Lett. 2014; 352(2):140–9. https://doi.org/10.1111/15746968.12367 PMID: 24372713
19. Nemzek JA, Xiao HY, Minard AE, Bolgos GL, Remick DG. Humane endpoints in shock research. Shock. 2004; 21(1):17–25. Epub 2003/12/17. https://doi.org/10.1097/01.shk.0000101667.49265.fdPMID: 14676679
20. Issara-Amphorn J, Surawut S, Worasilchai N, Thim-Uam A, Finkelman M, Chindamporn A, et al. The Synergy of Endotoxin and (1—>3)-beta-D-Glucan, from Gut Translocation, Worsens Sepsis Severity in a Lupus Model of Fc Gamma Receptor IIb-Deficient Mice. J Innate Immun. 2018; 10(3):189–201. https://doi.org/10.1159/000486321 PMID: 29393221
21. Lemee L, Dhalluin A, Testelin S, Mattrat MA, Maillard K, Lemeland JF, et al. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile. J Clin Microbiol. 2004; 42(12):5710–4. https://doi.org/10.1128/JCM.42.12.5710-5714.2004PMID: 15583303
22. Boonma P, Spinler JK, Venable SF, Versalovic J, Tumwasorn S. Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells. BMC Microbiol. 2014; 14:177. https://doi.org/10.1186/1471-2180-14-177 PMID: 24989059
23. Panpetch W, Chancharoenthana W, Bootdee K, Nilgate S, Finkelman M, Tumwasorn S, et al. Lactobacillus rhamnosus L34 Attenuates Gut Translocation-Induced Bacterial Sepsis in Murine Models of Leaky Gut. Infect Immun. 2018; 86(1). https://doi.org/10.1128/IAI.00700-17 PMID: 29038123
24. Panpetch W, Spinler JK, Versalovic J, Tumwasorn S. Characterization of Lactobacillus salivarius strains B37 and B60 capable of inhibiting IL-8 production in Helicobacter pylori-stimulated gastric epithelial cells. BMC Microbiol. 2016; 16(1):242. https://doi.org/10.1186/s12866-016-0861-x PMID: 27756217
25. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000; 12(2):121–7. PMID: 10714678
26. Tsoni SV, Brown GD. beta-Glucans and dectin-1. Ann N Y Acad Sci. 2008; 1143:45–60. https://doi.org/10.1196/annals.1443.019 PMID: 19076344
27. Francino MP. Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances. Front Microbiol. 2015; 6:1543. https://doi.org/10.3389/fmicb.2015.01543 PMID: 26793178
28. Iizumi T, Taniguchi T, Yamazaki W, Vilmen G, Alekseyenko AV, Gao Z, et al. Effect of antibiotic pretreatment and pathogen challenge on the intestinal microbiota in mice. Gut Pathog. 2016; 8:60. https://doi.org/10.1186/s13099-016-0143-z PMID: 27891184
29. Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K, et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med. 2017; 15(1):73. https://doi.org/10.1186/s12967-017-1175-y PMID: 28388917
30. Hill DA, Hoffmann C, Abt MC, Du Y, Kobuley D, Kirn TJ, et al. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol. 2010; 3(2):148–58. https://doi.org/10.1038/mi.2009.132 PMID: 19940845
31. Kumamoto CA. Inflammation and gastrointestinal Candida colonization. Curr Opin Microbiol. 2011; 14 (4):386–91. https://doi.org/10.1016/j.mib.2011.07.015 PMID: 21802979
32. BERBEE ML. The phylogeny of plant and animal pathogens in the Ascomycota. Physiological and Molecular Plant Pathology. 2001; 59:165–87.
33. Guitard J, Atanasova R, Brossas JY, Meyer I, Gits M, Marinach C, et al. Candida inconspicua and Candida norvegensis: new insights into identification in relation to sexual reproduction and genome organization. J Clin Microbiol. 2015; 53(5):1655–61. https://doi.org/10.1128/JCM.02913-14 PMID: 25762773
34. Colombo AL, Padovan AC, Chaves GM. Current knowledge of Trichosporon spp. and Trichosporono-sis. Clin Microbiol Rev. 2011; 24(4):682–700. https://doi.org/10.1128/CMR.00003-11 PMID: 21976604
35. Giraldo A, Sutton DA, Samerpitak K, de Hoog GS, Wiederhold NP, Guarro J, et al. Occurrence of Ochroconis and Verruconis species in clinical specimens from the United States. J Clin Microbiol. 2014; 52(12):4189–201. https://doi.org/10.1128/JCM.02027-14 PMID: 25232157
36. Gaulin E, Jacquet C, Bottin A, Dumas B. Root rot disease of legumes caused by Aphanomyces euteiches. Mol Plant Pathol. 2007; 8(5):539–48. https://doi.org/10.1111/j.1364-3703.2007.00413.xPMID: 20507520
37. Guitard J, Angoulvant A, Letscher-Bru V, L’Ollivier C, Cornet M, Dalle F, et al. Invasive infections due to Candida norvegensis and Candida inconspicua: report of 12 cases and review of the literature. Med Mycol. 2013; 51(8):795–9. Epub 2013/07/17. https://doi.org/10.3109/13693786.2013.807444 PMID: 23855412
38. Qiu X, Zhang F, Yang X, Wu N, Jiang W, Li X, et al. Changes in the composition of intestinal fungi and their role in mice with dextran sulfate sodium-induced colitis. Sci Rep. 2015; 5:10416. https://doi.org/10.1038/srep10416 PMID: 26013555
39. Hecht G, Pothoulakis C, LaMont JT, Madara JL. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest. 1988; 82(5):1516–24. Epub 1988/11/01. https://doi.org/10.1172/JCI113760 PMID: 3141478
40. Finkelman M THDamoβ-D-gwLal-brIYS, Castranova V (eds). Toxicity of 1–>3-Beta-glucan, Glucans as a Marker of Fungal exposure. London: Taylor & Francis, 2005, 179–97.
41. Yang AM, Inamine T, Hochrath K, Chen P, Wang L, Llorente C, et al. Intestinal fungi contribute to development of alcoholic liver disease. J Clin Invest. 2017; 127(7):2829–41. Epub 2017/05/23. https://doi.org/10.1172/JCI90562 PMID: 28530644